Skip to main content

Unstable Angina

2
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Green Valley Pharmaceuticals
1 program
1
0.9% Sodium Chloride InjectionPhase 41 trial
Active Trials
NCT03037047Unknown320Est. Dec 2018
Abbott
AbbottABBOTT PARK, IL
1 program
1
iSTAT point of care analyzerPhase 41 trial
Active Trials
NCT00276432Completed350Est. Aug 2007
GE HealthCare
1 program
Prevalence of Sleep Disordered BreathingN/A1 trial
Active Trials
NCT01011647Terminated53Est. Dec 2011
Sanofi
SanofiPARIS, France
1 program
ALX-0081PHASE_21 trial
Active Trials
NCT01020383Completed364Est. Mar 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Green Valley Pharmaceuticals0.9% Sodium Chloride Injection
AbbottiSTAT point of care analyzer
SanofiALX-0081
GE HealthCarePrevalence of Sleep Disordered Breathing

Clinical Trials (4)

Total enrollment: 1,087 patients across 4 trials

NCT03037047Green Valley Pharmaceuticals0.9% Sodium Chloride Injection

Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris

Start: May 2016Est. completion: Dec 2018320 patients
Phase 4Unknown
NCT00276432AbbottiSTAT point of care analyzer

Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.

Start: Nov 2005Est. completion: Aug 2007350 patients
Phase 4Completed
NCT01020383SanofiALX-0081

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Start: Sep 2009Est. completion: Mar 2012364 patients
Phase 2Completed
NCT01011647GE HealthCarePrevalence of Sleep Disordered Breathing

Prevalence of Sleep Disordered Breathing

Start: Nov 2009Est. completion: Dec 201153 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.